The leaders of Fuyang Fuhe Modern Industrial Park investigated and investigated Meisaitai Biology

  On the morning of July 17th, Wang Chengshuang, a member of the Party Working Committee and Deputy Director of the Management Committee of Fuhe Modern Industrial Park, Liu Jun, Director of the Investment Promotion Bureau, and Peng Chunsheng, Chief Economist of Fuhe Investment Company, visited Anhui Meisaitai Biotechnology for a visit and negotiation. Xiong Zhijun, General Manager of Anhui Meisaitai Biotechnology, warmly welcomes the arrival of leaders from Fuhe Modern Industrial Park.

  At the meeting, General Manager Xiong Zhijun gave a detailed introduction to the company's development history, main products, technical characteristics, market applications, and strategic planning for the entire IVD industry chain layout. General Manager Xiong Zhijun pointed out: "In the future, Meisaitai Biotechnology will continue to deepen the research and development of in vitro diagnostic raw materials and overall solutions, continuously promote resource collaboration and value sharing within the industry through technological innovation and high-quality product services, and enable the development of diagnostic technology to benefit more people and the cause of human health.

  Director Wang Chengshuang and his team visited the R&D and production center of Meisaitai Biotechnology, and listened to the company's scientific research and innovative technologies, as well as the future trends of the IVD industry in China. They expressed appreciation for Meisaitai Biotechnology, believing that the core raw materials of in vitro diagnostic reagents are particularly crucial in the medical and health industry chain. Meisaitai Biotechnology needs to invest heavily in research and development work in this field, guided by innovative development, and launch more high-tech products, Continuously injecting fresh technological blood into the domestic medical and health industry, and assisting the steady and magnificent development of the domestic in vitro diagnostic industry.

  Liu Jun, Director of the Investment Promotion Bureau, fully affirmed the research and development, technology, and innovation achievements of Meisaitai Biotechnology. We hope that both sides can engage in deeper and higher level exchanges and cooperation, and jointly promote the rapid development of the biopharmaceutical industry. Make greater contributions to the cause of health.

  During this inspection, the leaders of Fuhe Modern Industrial Park and their team are full of affirmation for the development of Meisaitai Biology. Both sides exchanged views on future cooperation, product incubation, technological innovation, and other fields, laying a solid foundation for further deepening industrial cooperation in the future.

  Technology is the first element of enterprise development, innovation is the primary soul of enterprise survival, and culture is the fundamental foundation for enterprise continuity. Meisaitai Biotechnology will make unremitting efforts to increase product technology research and development, promote the transformation of innovative achievements, and demonstrate greater achievements in promoting high-quality development, making continuous contributions to the development of life and health.